scispace - formally typeset
C

Carrie A. Redlich

Researcher at Yale University

Publications -  157
Citations -  5854

Carrie A. Redlich is an academic researcher from Yale University. The author has contributed to research in topics: Occupational asthma & Hexamethylene diisocyanate. The author has an hindex of 38, co-authored 143 publications receiving 5139 citations. Previous affiliations of Carrie A. Redlich include University of Toronto & University of Tennessee Health Science Center.

Papers
More filters
Journal ArticleDOI

Glutathione protects human airway proteins and epithelial cells from isocyanates

TL;DR: The ability of GSH to modulate key chemical reactions, thought to be central to the development of human isocyanate allergy, has not been directly analyzed under biologic exposure conditions.
Journal ArticleDOI

Isocyanates and human health: multistakeholder information needs and research priorities.

TL;DR: Recommendations were summarized regarding knowledge gaps and research priorities in the following areas: worker and consumer exposures; toxicology, animal models, and biomarkers; human cancer risk; environmental exposure and monitoring; and respiratory epidemiology and disease, and occupational health surveillance.
Journal ArticleDOI

Determinants of isocyanate exposures in auto body repair and refinishing shops

TL;DR: As part of the Survey of Painters and Repairers of Auto bodies by Yale (SPRAY), the determinants of isocyanate exposure in auto body repair shops were evaluated and identified the shop annual income was the most important determinant.
Book ChapterDOI

Polyisocyanates and Their Prepolymers

TL;DR: Polyisocyanates, a group of low-molecular-weight cross-linking agents, are the most commonly identified cause of occupational asthma (OA) worldwide (1-3).
Journal ArticleDOI

Short-term outcomes in older intensive care unit patients with dementia.

TL;DR: The authors' study documents no difference in outcomes from ICU care in older patients with and without dementia, and assumes that outcomes from critical care are less favorable in patients with dementia should not drive treatment decisions in the ICU.